Crossmark

Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy

Crossref DOI link: https://doi.org/10.1038/s41409-018-0256-8

Published Online: 2018-06-13

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Martínez-Muñoz, M. E.

Forés, R.

Lario, A.

Bautista, G.

Bueno, J. L.

de Miguel, C.

Navarro, B.

De Laiglesia, A.

Sánchez-Guerrero, A.

Cabrera, J. R.

Duarte, R. F.
License Information

Text and Data Mining valid from 2018-06-13
More Information

Article History

Received: 8 May 2018

Revised: 28 May 2018

Accepted: 29 May 2018

First Online: 13 June 2018

Compliance with ethical standards

:

: R.F.D. reports receiving fees for serving as a speaker and on advisory boards for Jazz Pharmaceuticals and Omeros Pharmaceuticals. J.R.C. reports receiving research funds from Jazz Pharmaceuticals. The other authors declare that they have no conflict of interest.